DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

Acne severity and scarring risk

Essential points for quick revision.

Synopsis

Classify acne by lesion type, inflammatory burden, distribution and personal impact; identify scarring risk early; and match treatment intensity and referral to the whole presentation.

  • Look for open and closed comedones, inflammatory papules, pustules, nodules, active scars and persistent pigment change across the face, chest and back.
  • Severity is multidimensional: count and depth of lesions matter, but distribution, scarring trajectory, persistent pigment change and psychological impact can justify earlier escalation.
  • Mild-to-moderate disease usually has comedones with limited papules or pustules and no nodules; moderate-to-severe disease has many inflammatory lesions or nodules and often truncal involvement.

Key red flags

Acne fulminans, systemic illness, rapidly destructive nodules, severe psychological distress, self-harm thoughts, diagnostic uncertainty or an androgenising syndrome require urgent or specialist assessment rather than routine topical escalation.

Acne fulminans

Sudden ulcerating or crusted painful nodules with fever, malaise or joint pain require same-day specialist discussion because treatment can differ from ordinary severe acne.

Investigation priorities

01
Structured morphology and distribution recordFirst step

Establish severity, scar trajectory and a reproducible baseline before treatment.

Management branches

Mild to moderate acneStart a complete topical course

Comedones and a limited inflammatory burden occur without nodules, rapid scarring or major psychological risk.

  1. Agree one NICE first-line twelve-week option, commonly fixed adapalene with benzoyl peroxide, after checking pregnancy potential, contraindications and preferences.
  2. Apply to the whole acne-prone area, introduce alternate-day or short-contact use if irritation is likely, and support with gentle non-comedogenic cleanser, moisturiser and sunscreen.

Key medicines

Adapalene 0.1% with benzoyl peroxide 2.5% gelApply a thin film to the entire clean, dry acne-affected area once daily in the evening; reduce to alternate-day or short-contact application initially if irritation occurs.
Lymecycline 408 mg capsulesTake one capsule orally once daily as part of a twelve-week acne combination, using the current product information for administration and patient-specific adjustment.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom